Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2016

Sep 6, 2016

30198_dirs_2016-09-06_ddb54a78-b04c-4876-aff7-4d60a92951bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-09-01

Reporting Person: LORD JONATHAN T MD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-09-01 Common Stock S 10000.0 $91.5 Disposed 52820 Direct

Footnotes

F1: Since the date of the reporting person's last Form 4, 63,553 shares of Dexcom Inc. Common stock were transferred to his former spouse pursuant to a domestic relations order. Included in this number are 4,791 unvested restricted stock units which were granted on May 25, 2016 and shall vest on May 25, 2017.